Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions

被引:7
作者
Caruthers, Regine L.
Johnson, Cary E.
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan Hosp & Hlth Ctr, Pediat Cardiothorac Unit, Ann Arbor, MI USA
[3] Univ Michigan, Coll Pharm, Dept Clin Sci, Ann Arbor, MI 48109 USA
[4] Univ Michigan Hosp & Hlth Ctr, Dept Pharm, Ann Arbor, MI USA
关键词
antihyperammonemic agents; color; compounding; concentration; contamination; hydrogen ion concentration; odors; sodium phenylbutyrate; stability; storage; suspensions; taste; vehicles;
D O I
10.2146/ajhp060450
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. In an effort to minimize barriers to compliance and adherence and to improve the accuracy of dosage measurement, sugar-containing and sugar-free sodium phenylbutyrate suspensions were formulated, and the stability of these products over a 90-day period was determined. Methods. An oral suspension of sodium phenylbutyrate 200 mg/mL was prepared by thoroughly grinding 12 g of Sodium Phenylbutyrate Powder, USP, in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of each formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and were stored at room temperature. A 500-mu L sample was withdrawn from each of the six bottles with a micropipette immediately after preparation and at 7,14,28,60, and 90 days. After further dilution to an expected concentration of 100 mu g/mL with the mobile phase, the samples were assayed by high-performance liquid chromatography. Stability was defined as the retention of at least 90% of the initial concentration. Results. At least 95% of the initial sodium phenylbutyrate concentration remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH and no visible microbial growth in any sample. Conclusion. Extemporaneously compounded suspensions of sodium phenylbutyrate, 200 mg/mL, in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature.
引用
收藏
页码:1513 / 1515
页数:3
相关论文
共 5 条
[1]   Alternative pathway therapy for urea cycle disorders: Twenty years later [J].
Batshaw, ML ;
MacArthur, RB ;
Tuchman, M .
JOURNAL OF PEDIATRICS, 2001, 138 (01) :S46-S54
[2]   PHENYLACETYLGLUTAMINE MAY REPLACE UREA AS A VEHICLE FOR WASTE NITROGEN-EXCRETION [J].
BRUSILOW, SW .
PEDIATRIC RESEARCH, 1991, 29 (02) :147-150
[3]   Alternative pathway therapy for urea cycle disorders [J].
Feillet, F ;
Leonard, JV .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 :101-111
[4]  
*LEXI COMP INC, SOD PHEN PED DRUG IN
[5]  
SCOTTSDALE AZ, 2003, BUPHENYL SODIUM PHEN